ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0056

Role of Socioeconomic and Cultural Factors in Racial Disparities in Disease Severity and Health Status of Patients with Axial Spondyloarthritis

Leila Muhieddine1, Shakaib Hayat2, Katja Reuter3, Charles Thomas4 and Marina Magrey5, 1Case Western Reserve University- Metrohealth Medical Center, Cleveland, OH, 2Case Western Reserve University-Metrohealth Medical Center, Cleveland, OH, 3University of Southern California, Keck School of Medicine, Los Angeles, CA, 4Case Western Reserve University, School of Medicine, Cleveland, OH, 5Case Western Reserve University School of Medicine, Cleveland, OH

Meeting: ACR Convergence 2020

Keywords: Disparities, Outcome measures, race/ethnicity, socioeconomic factors, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Healthcare Disparities in Rheumatology Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

To confront the persistent racial and ethnic disparities in health outcomes in the United States, it is imperative to study cultural and socioeconomic differences as potential contributors of worse disease severity among Black patients with AxSpA. In this two-phase, cross-sectional survey study, we aimed to identify differences in cultural, socioeconomic factors, and education levels among the Black and White patients with AxSpA in the United States.

Methods:

The first phase consisted of qualitative research to develop a questionnaire. A focus group including Black patients with AxSpA was convened at an urban medical center to investigate participants’ knowledge about SpA symptoms, disease course, and barriers to management of the disease. The focus group was audio-recorded, transcribed, and the feedback obtained was tabulated for trends. The survey content was generated using feedback from the focus group. Phase two of the study involved the distribution of the survey in person in a single rheumatology practice and nationwide electronically via social media (Facebook) and search engine marketing (Google search pages). The survey assessed respondent’s demographics, understanding of their disease, educational level, income level, employment status, information about medication use including biologic use, availability of primary and specialty care, shared decision-making, cultural and family influences, and trust of the medical system. Categorical variables were analyzed with Fischer’s Exact Test and ordinal variables with the Kruskal-Wallis Test. All tests were two-sided, with p< 0.05 considered significant.

Results:

A total of 120 surveys were completed (62.5% web-based, 37.5% in person). The total was was composed of 65% White participants with a mean age 51.9 ± 13.0 years, 25% Black participants with a mean age 56.3 ± 11.1 years, and 10% other. The mean BASDAI, BASFI, and ASAS HI among the two groups were not different as shown in Table 1. Black patients were less likely to have a post-secondary education (25.93% vs. 51.35%, P=.0256), be employed (24.14% vs. 45.45% p=.0491), use home remedies (23.33% vs. 51.32 p=.0079), and be fearful of medication side effects (30.00% vs. 62.34% p= .0046).  Black participants were more likely to be male (79.31% vs. 39.74% p= .0004). There was no significant difference in other survey questions among the two groups as shown in Table 2.

Conclusion:

While this study demonstrated a difference in three areas among Black and White patients with AxSpA (i.e., cultural beliefs, education, employment), we did not find significant differences in terms of diagnostic delays, access to physicians, rapport with physicians, access to medication, income, disease activity, function, and health status. Interventions to address the AxSpA health disparity gap can build on these findings.

Table 1. Disease Activity, Function and Health Status between Black and White participants.

Table. 2 Socioeconomic, cultural and other factors between Black and White participants.


Disclosure: L. Muhieddine, None; S. Hayat, None; K. Reuter, None; C. Thomas, None; M. Magrey, Novartis, 5, Eli Lilly, 5, AbbVie, 2, UCB, 2, Amgen, 2, Pfizer, 5, Janssen, 5.

To cite this abstract in AMA style:

Muhieddine L, Hayat S, Reuter K, Thomas C, Magrey M. Role of Socioeconomic and Cultural Factors in Racial Disparities in Disease Severity and Health Status of Patients with Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/role-of-socioeconomic-and-cultural-factors-in-racial-disparities-in-disease-severity-and-health-status-of-patients-with-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-socioeconomic-and-cultural-factors-in-racial-disparities-in-disease-severity-and-health-status-of-patients-with-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology